Clinical Trials Directory

Trials / Sponsors / Chroma Therapeutics

Chroma Therapeutics

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
UnknownExtension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia
Phase 22010-06-01
CompletedSafety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed
Acute Myeloid Leukemia, AML
Phase 22009-10-01
CompletedSafety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies
Hematological Disease, Lymphoid Malignancies
Phase 12008-12-01
CompletedSafety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours
Solid Tumor
Phase 12008-02-01
TerminatedClinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or
Carcinoma, Non-Small-Cell Lung
Phase 1 / Phase 22007-12-01
CompletedA Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or
Solid Tumor
Phase 12006-08-01
CompletedSafety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Multiple Myeloma
Phase 1 / Phase 22006-05-01
CompletedSafety Study to Evaluate CHR-2797 in Patients With Advanced Tumours
Advanced Solid Tumors
Phase 12004-10-01